Immunotherapy toxicities: An SGO clinical practice statement

R. E. O'Cearbhaill, L. Clark, R. N. Eskander, S. Gaillard, J. Moroney, E. Pereira, B. Pothuri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)25-35
Number of pages11
JournalGynecologic oncology
Volume166
Issue number1
DOIs
StatePublished - Jul 2022

Keywords

  • Cervical cancer
  • Checkpoint blockade
  • Endometrial cancer
  • Immunotherapy
  • Pembrolizumab
  • Toxicity

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this